Europe | Cafepharma

Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation

Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation

Drug Discovery and Development

EMA Recommends Hundreds of Drugs to be Suspended Over ‘Flawed Studies’

EMA Recommends Hundreds of Drugs to be Suspended Over ‘Flawed Studies’

WSJ Pharmalot

EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis

EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis

First Word Pharma

Boehringer Ingelheim

idiopathic pulmonary fibrosis

AbbVie’s hepatitis C drug gets European approval for sale

AbbVie’s hepatitis C drug gets European approval for sale

Marketwatch

Celgene: European Decision Not Best Case Scenario, Not Worst Case Either

Celgene: European Decision Not Best Case Scenario, Not Worst Case Either

Barron's

Orexigen diet pill recommended for approval in Europe

Orexigen diet pill recommended for approval in Europe

Yahoo/Reuters

AstraZeneca first-in-class ovarian cancer drug wins EU approval

AstraZeneca first-in-class ovarian cancer drug wins EU approval

Yahoo/Reuters

Celgene Hits 52-Week High on Positive CHMP Opinion

Celgene Hits 52-Week High on Positive CHMP Opinion

Yahoo/Zacks.com

Novartis says heart-failure drug wins faster review in Europe

Novartis says heart-failure drug wins faster review in Europe

Yahoo/Reuters

Once-weekly Lilly diabetes drug wins EU approval

Once-weekly Lilly diabetes drug wins EU approval

Yahoo/Reuters

Europe gives green light to AbbVie hepatitis C medicine, others

Europe gives green light to AbbVie hepatitis C medicine, others

Yahoo/Reuters

Boehringer Ingelheim

Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni

Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni

TheStreet.com

Gilead Sciences

For This Obesity Drug, Europe Trumps the U.S.

For This Obesity Drug, Europe Trumps the U.S.

Motley Fool

Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug

Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug

TheStreet.com

Glaxo files regulatory submissions for asthma drug candidate

Glaxo files regulatory submissions for asthma drug candidate

Seeking Alpha

AstraZeneca ovarian cancer drug wins European green light

AstraZeneca ovarian cancer drug wins European green light

Yahoo/Reuters

AstraZeneca looks to EU decision for next cancer drug boost

AstraZeneca looks to EU decision for next cancer drug boost

Yahoo/Reuters

Medtronic seeks EU approval for $43 bln Covidien deal

Medtronic seeks EU approval for $43 bln Covidien deal

Yahoo/Reuters

Does Gilead Sciences Have a European Problem?

Does Gilead Sciences Have a European Problem?

Barron's

Gilead Sciences

EU OKs Eli Lilly's $5.4B bid for Novartis division

EU OKs Eli Lilly's $5.4B bid for Novartis division

Yahoo/AP

1
2
3
4
5
6
7
8
9
…
next ›

Click here to subscribe to daily news headlines in your email inbox